Dyne Therapeutics Inc (DYN)
24.73
+1.04
(+4.37%)
USD |
NASDAQ |
Apr 26, 16:00
24.70
-0.03
(-0.12%)
After-Hours: 20:00
Dyne Therapeutics Net Income (Quarterly): -66.64M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -66.64M |
| September 30, 2023 | -60.21M |
| June 30, 2023 | -64.90M |
| March 31, 2023 | -44.19M |
| December 31, 2022 | -38.83M |
| September 30, 2022 | -41.38M |
| June 30, 2022 | -52.30M |
| March 31, 2022 | -35.58M |
| December 31, 2021 | -51.79M |
| Date | Value |
|---|---|
| September 30, 2021 | -42.58M |
| June 30, 2021 | -29.96M |
| March 31, 2021 | -24.97M |
| December 31, 2020 | -28.65M |
| September 30, 2020 | -13.92M |
| June 30, 2020 | -8.982M |
| March 31, 2020 | -7.886M |
| December 31, 2019 | -5.403M |
| September 30, 2019 | -5.871M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-66.64M
Minimum
Dec 2023
-5.403M
Maximum
Dec 2019
-34.67M
Average
-37.20M
Median
Net Income (Quarterly) Benchmarks
| Solid Biosciences Inc | -20.34M |
| Sana Biotechnology Inc | -88.12M |
| Tenaya Therapeutics Inc | -29.94M |
| Prime Medicine Inc | -65.64M |
| CEL-SCI Corp | -6.710M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 67.69M |
| EPS Diluted (Quarterly) | -1.09 |
| Enterprise Value | 1.904B |
| Earnings Yield | -15.93% |